Table 5.
Age and sex stratified hepatitis C-attributable liver cancer and hepatitis C-attributable hepatocellular carcinoma proportion calculations in the hepatitis C exposed population and in the total population, Georgia, 2015–2019
| Liver Cancer Analysis (All ICD-10 codes for hepatobiliary cancer diagnoses included) | |||||||
|---|---|---|---|---|---|---|---|
| Age (years) Strata | Sex Strata | Overall APe (APt) | |||||
|
18–35 APea (APtb) |
36–49 APe (APt) |
50–61 APe (APt) |
> 61 APe (APt) |
Males APe (APt) |
Females APe (APt) |
95.0% (11.4%) | |
| Hepatitis C positive | 90.6% (2.8%) | 95.13% (11.9%) | 96.4% (23.5%) | 95.1% (10.1%) | 92.3% (18.1%) | 96.1% (2.8%) | |
| HCC Sub-Analysis (Only hepatocellular carcinoma-specific ICD-10 code-C22.0- included) | |||||||
| Age (years) Strata | Sex Strata | Overall APe (APt) | |||||
|
18–35 APe (APt) |
36–49 APe (APt) |
50–61 APe (APt) |
> 61 APe (APt) |
Males APe (APt) |
Females APe (APt) |
94.1% (11.3%) | |
| Hepatitis C positive | 96.8% (3.0%) | 92.2% (11.5%) | 91.8% (22.1%) | 92.5% (9.5%) | 91.9% (17.8%) | 92.5% (3.5%) | |
aAttributable proportion in exposed population
bAttributable proportion in the total population